Incidence of symptomatic brain metastasis following radical radiotherapy for non-small cell lung cancer: Is there a role for prophylactic cranial irradiation?

British Journal of Radiology

Volumn 85, Issue 1020, 2012, Pages 1546-1550

  Khan, E ^a   Ismail, S ^a   Muirhead, Rebecca ^a  

^a BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN METASTASIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER STAGING; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; RADIOSURGERY; RETROSPECTIVE STUDY; SKULL IRRADIATION; STEREOTACTIC RADIOSURGERY; SYSTEMIC THERAPY;

BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CRANIAL IRRADIATION; HUMANS; INCIDENCE; LUNG NEOPLASMS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SCOTLAND;

EID: 84871177284     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/23314501     Document Type: Article

References (33)

1. Barnholtz-Sloan JS, Sloan AE, David FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastasis in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004;22:2865-72. (Pubitemid 41079905)
2. Lock M, Chow E, Pond GR, Do V, Danjoux C, Dinniwell R, et al. Prognostic factors in brain metastasis: can we determine patients who do not benefit from whole-brain radiotherapy? Clin Oncol 2004;16:332-8. (Pubitemid 38967253)
3. Borgelt G, Gelber R, Kramer S, Brady LW, Chang CH, Davis LW, et al. The palliation of brain metastasis: final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 1980;6:1-9. (Pubitemid 10103009)
4. Borgelt B, Gelber R, Larson M, Hendrickson F, Griffin T, Roth R. Ultra-rapid high dose irradiation schedules for the palliation of brain metastasis: final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 1981;7:1633-8. (Pubitemid 12212604)
5. Priestman TJ, Dunn J, Brada M, Rampling R, Baker PG. Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastasis. Clin Oncol 1996;8:308-15. (Pubitemid 26382027)
6. Ferrigno D, Buccheri G. Cranial computed tomography as a part of the initial staging procedures for patients with non-small cell lung cancer. Chest 1994;106:1025-9. (Pubitemid 24309535)
7. Hochstenbag MMH, Twignstra A, Hofman P, Wouters EF, ten Velde GP. MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment? Lung Cancer 2003;42:189-93. (Pubitemid 37268029)
8. Kormas P, Bradshaw JR, Jeyasingham K. Preoperative computed tomography of the brain in non-small cell bronchogenic carcinoma. Thorax 1992;47:106-8.
9. National Institute for Health and Clinical Excellence. Lung cancer: the diagnosis and treatment of lung cancer. Clinical Guideline 24. London, UK: NICE; 2011. Available from: http://www.guideline.gov/content.aspx?id=34282.
10. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Non-small cell lung cancer, v. 3. Fort Washington, PA: NCCN; 2011.
11. Auperin A, Le Pechoux C, Rolland E, Curran WJ, Furuse K, Fournel P, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 2010;28:2181-90.
12. Fenwick JD, Nahum AE, Malik ZI, Eswar CV, Hatton MQ, Laurence VM, et al. Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement. Clin Oncol 2009;21:343-60.
13. Van Baardwijk AV, Wanders R, Reymen B, Borger J, Ollers M, Dingemans AM, et al. First results of a phase II trial investigating individualized dose-escalation based on normal tissue constraints in concurrent chemo-radiation for locally advanced non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 2010;78:S108.
14. Albain KS. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 2009;374:379-86.
15. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastasis: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010;77:655-61.
16. Burt M, Wronski M, Arbit E, Gallcich JH. Resection of brain metastasis from non-small-cell lung carcinoma. Results of therapy. Memorial Sloan-Kettering Cancer Centre Thoracic Surgical Staff. J Thorac Cardiovasc Surg 1992;103:399-410.
17. Gaspar LE, Mehta MP, Patchell RA, Burri SH, Robinson PD, Morris RE, et al. The role of whole brain radiation therapy in the management of newly diagnosed brain metastasis: a systematic review and evidence-based clinical practice guideline. J Neuroncol 2010;96:17-32.
18. Flannery TW, Suntharaligam M, Regine WF, Chin LS, Krasna MJ, Shehata MK, et al. Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery. Int J Radiat Oncol Biol Phys 2008;72:19-23.
19. Auperin A, Arriagada R, Pignon J-P, Le Péchoux C, Gregor A, Stephens RJ, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 1999;341:476-84. (Pubitemid 29372887)
20. Slotman B, Faivre-Finn C, Kramer G, Rankin E, Snee M, Hatton M, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007;357:664-72. (Pubitemid 47267236)
21. Le Pechoux C, Dunant A, Senan S, Wolfson A, Quoix E, Faivre-Finn C, et al. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomized clinical trial. Lancet Oncol 2009;10:467-74.
22. Corn B, Moughan J, Knisely PS, Fox SW, Chakravarti A, Yung WK, et al. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole brain radiotherapy with or without thalidomide on Radiation Oncology Group (RTOG) trial 0118. Int J Radiat Oncol Biol Phys 2008;71:71-8.
23. Sun A, Bae K, Gore EM, Movsas B, Wong SJ, Meyers CA, et al. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. J Clin Oncol 2011;29:279-86.
24. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole brain irradiation: a randomized controlled trial. Lancet Oncol 2009;10:1037-44.
25. Gore EM, Bae K, Wong SJ, Sun A, Bonner JA, Schild SE, et al. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. J Clin Oncol 2011;29:272-8.
26. Khuntia D, Brown P, Li J, Mehta M. Whole brain radiotherapy in the management of brain metastases. J Clin Oncol 2006;24:1295-304. (Pubitemid 46622033)
27. Loeffler JS, Shrieve D. An overview of radiotherapy trials for the treatment of brain metastases. Oncology 1995;9:1212-16.
28. Germain F, Wai ES, Berthelet E, Truong PT, Lesperance M. Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy. Am J Clin Oncol 2008;31:561-6.
29. Win T, Laroche CM, Groves AM, Nathan J, Clements L, Screaton NJ. The value of performing head CT in screening for cerebral metastases in patients with potentially resectable non-small cell lung cancer: experience from a UK cardiothoracic centre. Clin Radiol 2004;59:935-8. (Pubitemid 39276935)
30. Hochstenbag MM, Twijnstra A, Hofman P, Wouters EF, ten Velde GP. MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment? Lung Cancer 2003;42:189-93. (Pubitemid 37268029)
31. de Cos Escuin JS, Menna DM, Gonzalez MA, Quirantes JZ, Vicente CD, Calvo MC. Silent brain metastasis in the initial staging of lung cancer: evaluation by computed tomography and magnetic resonance imaging. [In Spanish.] Arch Bronconeumol 2007;43:386-91. (Pubitemid 47360714)
32. Gaspar LE, Chanksy K, Albain KS, Vallieres E, Rusch V, Crowley JJ, et al. Time from treatment to subsequent diagnosis of brain metastasis in stage III non-small cell lung cancer: A retrospective review by the Southwest Oncology Group. J Clin Oncol 2005;23:2955-61. (Pubitemid 46224114)
33. Sanchez de Cos J, Sojo Gonzalez MA, Victoria Montero M, Pérez Calvo MC, Vicente MJ, Valle MH. Non-small cell lung cancer and silent brain metastasis: survival and prognostic factors. Lung Cancer 2009;63:140-5.